1. Spratt JS, Edwards M, Kubota T, Lindberg R, Tseng MT. Peritoneal carcinomatosis: Anatomy, physiology, diagnosis and management. Curr Prol Cancer 1986;10:553–584.
2. Sugarbaker PH, Cunliffe W, Belliveau J, et al. Rationale for early postoperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Reg Cancer Treat 1989;1:66–79.
3. Markman M, Howell SB, Lucas WE, Pfeifle CE, Green MR. Combination intraperitoneal chemotherapy with cisplatin, cytarabine, doxorubicin for refractoy ovarian carcinoma and other malignancies principally confiend to the peritoneal cavity. J Clin Oncol 1984;2: 1321–1325.
4. Jacquet P, Vidal-Jove J, Zhu B, Sugarbaker PH. Peritoneal carcinomatosis from gastrointestinal malignacy: Natural history and new prospects for management. Acta Chir Belg 1994;94:191–197.
5. Sugarbaker PH. Cytoreductive approach to peritoneal carcinomatosis: Peritonectomy and intraperitoneal chemotherapy. In Postgraduate Advances in Colorectal Surgery. Forum Medicum, 1991, II-X.